| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 10 4686-4692, Copyright © 1997 by American Association of Immunologists
ARTICLES |
MJ Cameron, GA Arreaza, P Zucker, SW Chensue, RM Strieter, S Chakrabarti and TL Delovitch
The John P. Robarts Research Institute, University of Western Ontario, London, Canada.
Beginning at the time of insulitis, nonobese diabetic (NOD) mice demonstrate a thymocyte and peripheral T cell proliferative hyporesponsiveness induced by TCR cross-linking, which is associated with reduced IL-2 and IL-4 secretion. We previously reported that NOD CD4+ T cell hyporesponsiveness is reversed completely in vitro by exogenous IL-4, and that administration of IL-4 to NOD mice prevents the onset of insulin-dependent diabetes mellitus (IDDM). This result suggested that T cell-mediated destruction of pancreatic islet beta cells may result from a hyporesponsiveness in regulatory Th2 cells favoring a Th1 cell-mediated environment in the pancreas. In the present study, we tested this possibility by analysis of the mechanisms of protection from IDDM afforded by IL-4 treatment in NOD mice. We show that IL-4 protects NOD mice from insulitis and IDDM when administered i.p. three times a week for 10 wk beginning at 2 wk of age. This occurs by the modulation of the homing of autoreactive cells to inflammatory sites and the stabilization of a protective Th2-mediated environment in the thymus, spleen, and pancreatic islets. Thus, IL-4 treatment favors the expansion of regulatory CD4+ Th2 cells in vivo and prevents the onset of insulitis and IDDM mediated by autoreactive Th1 cells.
This article has been cited by other articles:
|
|
 |
|
  S. Hussain and T. L. Delovitch Intravenous Transfusion of BCR-Activated B Cells Protects NOD Mice from Type 1 Diabetes in an IL-10-Dependent Manner J. Immunol., December 1, 2007; 179(11): 7225 - 7232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. King, L. A. Cassis, and A. Daugherty Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice Am. J. Pathol., December 1, 2007; 171(6): 2040 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inoue, T. Kaifu, A. Sugahara-Tobinai, A. Nakamura, J.-I. Miyazaki, and T. Takai Activating Fc{gamma} Receptors Participate in the Development of Autoimmune Diabetes in NOD Mice J. Immunol., July 15, 2007; 179(2): 764 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meagher, G. Arreaza, A. Peters, C. A. Strathdee, P. A. Gilbert, Q.-S. Mi, P. Santamaria, G. A. Dekaban, and T. L. Delovitch CCL4 Protects From Type 1 Diabetes by Altering Islet {beta}-Cell-Targeted Inflammatory Responses Diabetes, March 1, 2007; 56(3): 809 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hilliard, B. Hilliard, S.-J. Zheng, H. Sun, T. Miwa, W. Song, R. Goke, and Y. H. Chen Translational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4 J. Immunol., December 1, 2006; 177(11): 8095 - 8102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jaeschke, M. Rincon, B. Doran, J. Reilly, D. Neuberg, D. L. Greiner, L. D. Shultz, A. A. Rossini, R. A. Flavell, and R. J. Davis Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes PNAS, May 10, 2005; 102(19): 6931 - 6935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Mahamed, A. Marleau, M. Alnaeeli, B. Singh, X. Zhang, J. M. Penninger, and Y.-T. A. Teng G(-) Anaerobes-Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice Diabetes, May 1, 2005; 54(5): 1477 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Novak, L. Beaudoin, T. Griseri, and A. Lehuen Inhibition of T Cell Differentiation into Effectors by NKT Cells Requires Cell Contacts J. Immunol., February 15, 2005; 174(4): 1954 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schott-Ohly, A. Lgssiar, H.-J. Partke, M. Hassan, N. Friesen, and H. Gleichmann Prevention of Spontaneous and Experimentally Induced Diabetes in Mice With Zinc Sulfate-Enriched Drinking Water Is Associated with Activation and Reduction of NF-{kappa}B and AP-1 in Islets, Respectively Experimental Biology and Medicine, December 1, 2004; 229(11): 1177 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Machen, J. Harnaha, R. Lakomy, A. Styche, M. Trucco, and N. Giannoukakis Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells J. Immunol., October 1, 2004; 173(7): 4331 - 4341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lgssiar, M. Hassan, P. Schott-Ohly, N. Friesen, F. Nicoletti, W. L. Trepicchio, and H. Gleichmann Interleukin-11 Inhibits NF-{kappa}B and AP-1 Activation in Islets and Prevents Diabetes Induced with Streptozotocin in Mice Experimental Biology and Medicine, May 1, 2004; 229(5): 425 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-S. Mi, D. Ly, P. Zucker, M. McGarry, and T. L. Delovitch Interleukin-4 but not Interleukin-10 Protects Against Spontaneous and Recurrent Type 1 Diabetes by Activated CD1d-Restricted Invariant Natural Killer T-Cells Diabetes, May 1, 2004; 53(5): 1303 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, K. V. Salojin, Q.-S. Mi, M. Grattan, T. C. Meagher, P. Zucker, and T. L. Delovitch Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Complex: Therapeutic Efficacy and Mechanism of Protection against Type 1 Diabetes Endocrinology, February 1, 2004; 145(2): 627 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Bergman, N. Duarte, S. Campino, M. Lundholm, V. Motta, K. Lejon, C. Penha-Goncalves, and D. Holmberg Diabetes Protection and Restoration of Thymocyte Apoptosis in NOD Idd6 Congenic Strains Diabetes, July 1, 2003; 52(7): 1677 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Seifarth, S. Pop, B. Liu, C. P. Wong, and R. Tisch More Stringent Conditions of Plasmid DNA Vaccination Are Required to Protect Grafted Versus Endogenous Islets in Nonobese Diabetic Mice J. Immunol., July 1, 2003; 171(1): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Mabley, P. Pacher, G. J. Southan, A. L. Salzman, and C. Szabo Nicotine Reduces the Incidence of Type I Diabetes in Mice J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Grattan, Q.-S. Mi, C. Meagher, and T. L. Delovitch Congenic Mapping of the Diabetogenic Locus Idd4 to a 5.2-cM Region of Chromosome 11 in NOD Mice: Identification of Two Potential Candidate Subloci Diabetes, January 1, 2002; 51(1): 215 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, I. Bergerot, J. F. Elliott, L. C. Harrison, N. Abiru, G. S. Eisenbarth, and T. L. Delovitch Evidence That a Peptide Spanning the B-C Junction of Proinsulin Is an Early Autoantigen Epitope in the Pathogenesis of Type 1 Diabetes J. Immunol., November 1, 2001; 167(9): 4926 - 4935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Tran, N. Carter, X. Y. He, T. S. Spicer, K. M. Plain, M. Nicolls, B. M. Hall, and S. J. Hodgkinson Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4 Int. Immunol., September 1, 2001; 13(9): 1109 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tisch, B. Wang, M. A. Atkinson, D. V. Serreze, and R. Friedline A Glutamic Acid Decarboxylase 65-Specific Th2 Cell Clone Immunoregulates Autoimmune Diabetes in Nonobese Diabetic Mice J. Immunol., June 1, 2001; 166(11): 6925 - 6936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Laloux, L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen NK T Cell-Induced Protection Against Diabetes in V{{alpha}}14-J{{alpha}}281 Transgenic Nonobese Diabetic Mice Is Associated with a Th2 Shift Circumscribed Regionally to the Islets and Functionally to Islet Autoantigen J. Immunol., March 15, 2001; 166(6): 3749 - 3756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, K. V. Salojin, and T. L. Delovitch CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription Int. Immunol., March 1, 2001; 13(3): 377 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Fort, R. Lesley, N. J. Davidson, S. Menon, F. Brombacher, M. W. Leach, and D. M. Rennick IL-4 Exacerbates Disease in a Th1 Cell Transfer Model of Colitis J. Immunol., February 15, 2001; 166(4): 2793 - 2800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tisch, B. Wang, D. J. Weaver, B. Liu, T. Bui, J. Arthos, and D. V. Serreze Antigen-Specific Mediated Suppression of {{beta}} Cell Autoimmunity by Plasmid DNA Vaccination J. Immunol., February 1, 2001; 166(3): 2122 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Serreze, H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation J. Immunol., January 15, 2001; 166(2): 1352 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Pauza, A. Nguyen, T. Wolfe, I-C. Ho, L. H. Glimcher, M. von Herrath, and D. Lo Variable Effects of Transgenic c-Maf on Autoimmune Diabetes Diabetes, January 1, 2001; 50(1): 39 - 46. [Abstract] [Full Text]
|
|
|
|
|
|
S. Nervi, C. Atlan-Gepner, B. Kahn-Perles, P. Lecine, B. Vialettes, J. Imbert, and P. Naquet Specific Deficiency of p56lck Expression in T Lymphocytes from Type 1 Diabetic Patients J. Immunol., November 15, 2000; 165(10): 5874 - 5883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Chapman, K.-S. Kim, S. Tracy, J. Jackson, K. Höfling, J. S. Leser, J. Malone, and P. Kolbeck Coxsackievirus Expression of the Murine Secretory Protein Interleukin-4 Induces Increased Synthesis of Immunoglobulin G1 in Mice J. Virol., September 1, 2000; 74(17): 7952 - 7962. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Cameron, G. A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M. D. Burdick, R. M. Strieter, D. N. Cook, and T. L. Delovitch Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes J. Immunol., July 15, 2000; 165(2): 1102 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Papaccio, F. Nicoletti, F. Aurelio Pisanti, K. Bendtzen, and M. galdieri Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferring in Vitro Antigen-Pulsed Syngeneic Dendritic Cells Endocrinology, April 1, 2000; 141(4): 1500 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Poulin and K. Haskins Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse J. Immunol., March 15, 2000; 164(6): 3072 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dahlen, G. Hedlund, and K. Dawe Low CD86 Expression in the Nonobese Diabetic Mouse Results in the Impairment of Both T Cell Activation and CTLA-4 Up-Regulation J. Immunol., March 1, 2000; 164(5): 2444 - 2456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tisch, B. Wang, and D. V. Serreze Induction of Glutamic Acid Decarboxylase 65-Specific Th2 Cells and Suppression of Autoimmune Diabetes at Late Stages of Disease Is Epitope Dependent J. Immunol., August 1, 1999; 163(3): 1178 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Gallichan, B. Balasa, J. D. Davies, and N. Sarvetnick Pancreatic IL-4 Expression Results in Islet-Reactive Th2 Cells That Inhibit Diabetogenic Lymphocytes in the Nonobese Diabetic Mouse J. Immunol., August 1, 1999; 163(3): 1696 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Verdaguer2, A. Amrani2, B. Anderson, D. Schmidt, and P. Santamaria Two Mechanisms for the Non-MHC-Linked Resistance to Spontaneous Autoimmunity J. Immunol., April 15, 1999; 162(8): 4614 - 4626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Bradley, V. C. Asensio, L.-K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick Islet-Specific Th1, But Not Th2, Cells Secrete Multiple Chemokines and Promote Rapid Induction of Autoimmune Diabetes J. Immunol., March 1, 1999; 162(5): 2511 - 2520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Seddon and D. Mason Regulatory T Cells in the Control of Autoimmunity: the Essential Role of Transforming Growth Factor beta and Interleukin 4 in the Prevention of Autoimmune Thyroiditis in Rats by Peripheral CD4+CD45RC- Cells and CD4+CD8- Thymocytes J. Exp. Med., January 18, 1999; 189(2): 279 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Jun, C.-S. Yoon, L. Zbytnuik, N. van Rooijen, and J.-W. Yoon The Role of Macrophages in T Cell-mediated Autoimmune Diabetes in Nonobese Diabetic Mice J. Exp. Med., January 18, 1999; 189(2): 347 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lehuen, O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J.-F. Bach, and R. C. Monteiro Overexpression of Natural Killer T Cells Protects Valpha 14-Jalpha 281 Transgenic Nonobese Diabetic Mice against Diabetes J. Exp. Med., November 16, 1998; 188(10): 1831 - 1839. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
